Trials / Completed
CompletedNCT03125135
Accuracy of Noninvasive Pulse Oximeter Sensor (MightySat RX)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
In this study, the level of oxygen within the blood will be reduced in a controlled manner by reducing the concentration of oxygen the study volunteer breathes. The accuracy of a noninvasive pulse oximeter sensor will be assessed by comparison to the oxygen saturation measurements from a laboratory blood gas analyzer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MightySat RX Pulse Oximeter Sensor | Noninvasive pulse oximeter finger sensor. |
Timeline
- Start date
- 2014-11-12
- Primary completion
- 2014-12-17
- Completion
- 2014-12-17
- First posted
- 2017-04-24
- Last updated
- 2021-02-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03125135. Inclusion in this directory is not an endorsement.